Valuation : STCube, Inc.

Market Cap 548B 404M 347M 326M 298M 557M 38.17B 561M 3.86B 1.5B 19.51B 1.52B 1.48B 62.83B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 491B 362M 311M 292M 267M 498M 34.18B 502M 3.45B 1.34B 17.47B 1.36B 1.33B 56.25B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24/10/24 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
26/08/24 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
28/03/24 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
06/09/23 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
21/03/23 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
08/03/22 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
28/12/20 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
18/12/20 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
12/07/20 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
02/03/20 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
25/05/18 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
25/04/18 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
19/09/16 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day+1.38%
1 week-2.54%
Current month-2.30%
1 month+12.24%
3 months-38.26%
6 months-9.63%
Current year-1.59%
1 week 7,850
Extreme 7850
8,360
1 month 7,710
Extreme 7710
9,570
Current year 6,010
Extreme 6010
22,500
1 year 6,010
Extreme 6010
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 62 29/03/2013
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 01/03/2014
Director TitleAgeSince
Director/Board Member 62 01/03/2013
Director/Board Member 54 01/03/2013
Director/Board Member 62 01/03/2014
Date Insider Type Main position Quantity % Market Cap. Importance
12/3/24 A Buy

Chief Technology Officer

164,014 0.2515%
12/3/24 A Buy

Chief Executive Officer

18,346 0.0281%
12/3/24 A Buy

Chief Financial Officer

47,582 0.0730%
Change 5-day change 1-year change 3-year change Capi.($)
+1.38%-2.54%+4.13%-37.54% 398M
-0.05%-4.32%+36.47%+28.68% 119B
+0.39%+11.51%+192.89%+880.92% 52.4B
+1.56%-6.58%+100.65%+302.05% 39.14B
-1.79%-6.55%+48.30%+170.17% 34.5B
-0.43%-3.28%+75.30%+86.61% 28.81B
-0.01%-3.05%+11.52%+47.10% 28.11B
+0.60%-3.96%-5.17%-0.95% 27.1B
+0.67%-2.18%+11.28%+67.62% 18.2B
+1.54%-1.32%+16.56%+30.40% 16.61B
Average +0.40%-2.69%+49.19%+157.51% 36.45B
Weighted average by Cap. +0.16%-2.98%+62.81%+199.67%

Financials

2024 2025
Net sales 11.3B 8.32M 7.16M 6.72M 6.15M 11.47M 787M 11.57M 79.49M 30.96M 402M 31.25M 30.57M 1.29B 6.98B 5.14M 4.43M 4.15M 3.8M 7.09M 486M 7.15M 49.14M 19.14M 249M 19.32M 18.9M 800M
Net income -21.44B -15.79M -13.59M -12.75M -11.66M -21.77M -1.49B -21.94M -151M -58.74M -763M -59.3M -58M -2.46B -21.8B -16.06M -13.82M -12.97M -11.86M -22.14M -1.52B -22.32M -153M -59.73M -776M -60.3M -58.99M -2.5B
Net Debt -79.55B -58.6M -50.42M -47.31M -43.29M -80.79M -5.54B -81.43M -560M -218M -2.83B -220M -215M -9.12B -57.42B -42.3M -36.39M -34.15M -31.24M -58.32M -4B -58.78M -404M -157M -2.04B -159M -155M -6.58B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
03/09/26 8,070.00 +1.38% 98,906
02/09/26 ₩7,960.00 -4.33% 124,468
01/09/26 ₩8,320.00 +0.73% 74,003
31/08/26 ₩8,260.00 +0.98% 83,816
28/08/26 ₩8,180.00 +1.74% 70,190
  1. Stock Market
  2. Stocks
  3. A052020 Stock